购物车
- 全部删除
- 您的购物车当前为空
LUF6096 (CF-602) 是一种有效的腺苷 A3 受体 (adenosine A3 receptor) 变构增强剂。LUF6096 对任何腺苷受体显示出低正构亲和力。LUF6096 在心肌缺血/再灌注损伤中显示出保护作用。
为众多的药物研发团队赋能,
让新药发现更简单!
LUF6096 (CF-602) 是一种有效的腺苷 A3 受体 (adenosine A3 receptor) 变构增强剂。LUF6096 对任何腺苷受体显示出低正构亲和力。LUF6096 在心肌缺血/再灌注损伤中显示出保护作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 490 | 现货 | |
2 mg | ¥ 738 | 现货 | |
5 mg | ¥ 1,180 | 现货 | |
10 mg | ¥ 1,910 | 现货 | |
25 mg | ¥ 3,130 | 现货 | |
50 mg | ¥ 4,420 | 现货 | |
100 mg | ¥ 5,980 | 现货 | |
500 mg | 询价 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,310 | 现货 |
产品描述 | LUF6096 (CF-602) is a potent allosteric enhancer of the adenosine A3 receptor, exhibiting the capability to enhance agonist binding allosterically while demonstrating low orthosteric affinity across adenosine receptors. It displays protective effects in myocardial ischemia/reperfusion injury. |
体外活性 | LUF6096 (10 μM; 30-120 min) decreases the dissociation rate of 125I-AB-MECA from the A3 receptor by 2.5 times in CHO cell membranes. LUF6096 (10 μM; pretreated for 15 min) significantly enhances the intrinsic activity of Cl-IB-MECA for the inhibition of the forskolin-stimulated cAMP production in CHO cells[1]. |
体内活性 | LUF6096 (twice i.v. bolus for 0.5 mg/kg or single i.v. bolus for 1 mg/kg) protects against myocardial ischemia/reperfusion injury in dogs[1]. |
别名 | CF-602 |
分子量 | 414.33 |
分子式 | C22H21Cl2N3O |
CAS No. | 1116652-18-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (96.54 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.